Rishikesh Gupta

Rishikesh Gupta

Auto-generated profile, based on publicly available information

Rishikesh Gupta

Institute of Pharmacy, Bundelkhand University, Jhansi, India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
Alok Kumar MahorAlok Kumar Mahor
Alok Kumar Mahor
SPSunil Kumar Prajapati
Sunil Kumar Prajapati
AVAmita Verma
Amita Verma
RGRishikesh Gupta
Rishikesh Gupta
Arun K. IyerArun K. Iyer
Arun K. Iyer
PKPrashant Kesharwani
Prashant Kesharwani

6 November 2023 in Journal of Nanotechnology
Verified
Journal Article
Open access
PDF file
Alok Kumar MahorAlok Kumar Mahor
Alok Kumar Mahor
PSPrem Singh
Prem Singh
RGRishikesh Gupta
Rishikesh Gupta
PBPeeyush Bhardwaj
Peeyush Bhardwaj
PRPriyanka Rathore
Priyanka Rathore
Kuldeep BansalKuldeep Bansal
Kuldeep Bansal
Drug delivery via the oral route has always been challenging for poorly soluble drugs. Acid-induced hydrolysis, enzymatic degradation, and poor mucosal absorbency remain the primary hiccups for effective oral delivery of medications. With the advent of nanotechnology, nanostructured lipid carriers (NLCs) have emerged as a promising delivery carrier that can circumvent gastrointestinal tract (GIT) barriers hindering the solubility and bioavailability of such drugs. These NLCs can efficiently transport drug moieties across intestinal membranes shielding medications from intestinal pH and enzymatic degradation. Because they are composed of lipidic materials, they can be easily absorbed or taken up by various pathways such as transcellular absorption, paracellular transport, and M-cell uptake. Such mechanisms not only improve the absorption and solubility of drugs but also augment bioavailability and residence time and may bypass first-pass metabolism. This review explores the diverse applications of nanostructured lipid carriers (NLCs) in oral drug delivery for various medical conditions, shedding light on their current regulatory status, including FDA-approved options and those in pre/clinical stages. The review also features patented NLC formulations. It provides valuable insights into how NLCs can be harnessed for effective oral drug delivery and outlines recent advancements in optimizing their performance to tackle gastrointestinal barriers, thus opening new possibilities for NLCs in future pharmaceutical applications.

1 October 2017 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
MSMadhuri Shringirishi
Madhuri Shringirishi
Alok Kumar MahorAlok Kumar Mahor
Alok Kumar Mahor
RGRishikesh Gupta
Rishikesh Gupta
SPSunil Kumar Prajapati
Sunil Kumar Prajapati
Kuldeep BansalKuldeep Bansal
Kuldeep Bansal
PKPrashant Kesharwani
Prashant Kesharwani

1 September 2014 in Asian Pacific Journal of Tropical Biomedicine
Verified
Journal Article
Open access
RGRishikesh Gupta
Rishikesh Gupta
SPSunil Kumar Prajapati
Sunil Kumar Prajapati
SPSnigdha Pattnaik
Snigdha Pattnaik
PBPeeyush Bhardwaj
Peeyush Bhardwaj
ObjectiveTo develop and characterize multiple-unit-type oral floating microsphere of famotidine to prolong gastric residence time and to target stomach ulcer.MethodsThe floating microspheres were prepared by modified solvent evaporation method. Eudragit S-100 was used as polymer. Microspheres were characterized for the micromeritic properties, floating behavior, entrapment efficiency and scanning electron microscopy. The in-vitro release studies and floating behavior were studied in simulated gastric fluid at pH 1.2. Different drug release kinetics models were also applied for all the batches. Selected formulations were also subjected for X-ray radiographic study.ResultsFloating microspheres were successfully prepared by modified solvent evaporation technique. Microspheres showed passable flow properties. The maximum yield of microspheres was up to (95.11±0.35)%. On the basis of optical microscopy particle size range was found to be ranging from (52.18±182.00) to (91.64±5.16) μm. Scanning electron microscopy showed their spherical size, perforated smooth surface and a cavity inside microspheres. Microspheres were capable to float up to 20 h in simulated gastric fluid. X-ray radiographic studies also proved its better retention in the stomach.ConclusionsOn the basis of the results, such dosage forms may be a good candidate for stomach targeting and may be dispensed in hard gelatin capsules

1 December 2016 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
Alok Kumar MahorAlok Kumar Mahor
Alok Kumar Mahor
SPSunil Kumar Prajapati
Sunil Kumar Prajapati
AVAmita Verma
Amita Verma
RGRishikesh Gupta
Rishikesh Gupta
TSThakur Raghu Raj Singh
Thakur Raghu Raj Singh
PKPrashant Kesharwani
Prashant Kesharwani

30 August 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
MKMohammad Kasif
Mohammad Kasif
RGRishikesh Gupta
Rishikesh Gupta
PSPrem Singh
Prem Singh
PBPeeyush Bhardwaj
Peeyush Bhardwaj
RGRohit Goyal
Rohit Goyal
Alok Kumar MahorAlok Kumar Mahor
Alok Kumar Mahor